CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- operating
- EIN
- 223542636
- Phone
- 2017502646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $34,590
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-04-26 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion | +8,230,453 | 30,496,549 | ||
| 2013-04-26 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Series E Convertible Preferred Stock | −200 | $1,000.00 | $200K | 1,600 |
| 2013-04-26 | NIGALAYE ASHOK G Chief Scientific Officer | Other disposition · Warrants | −13,272,999 | 26,727,001 | ||
| 2013-04-26 | EPIC PHARMA LLC 10% owner | Returned to the company | −243,926 | $0.08 | $20K | 14,666,740 |
| 2013-04-26 | EPIC PHARMA LLC 10% owner | Conversion | +8,230,453 | 22,897,193 | ||
| 2013-04-26 | EPIC PHARMA LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −200 | $1,000.00 | $200K | 1,600 |
| 2013-04-26 | EPIC PHARMA LLC 10% owner | Other disposition · Warrants | −13,272,999 | 26,727,001 | ||
| 2013-04-26 | EPIC INVESTMENTS, LLC 10% owner | Returned to the company | −243,926 | $0.08 | $20K | 14,666,740 |
| 2013-04-26 | EPIC INVESTMENTS, LLC 10% owner | Conversion | +8,230,453 | 22,897,193 | ||
| 2013-04-26 | EPIC INVESTMENTS, LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −200 | $1,000.00 | $200K | 1,600 |
| 2013-04-26 | EPIC INVESTMENTS, LLC 10% owner | Other disposition · Warrants | −13,272,999 | 26,727,001 | ||
| 2013-04-25 | POTTI RAM 10% owner | Returned to the company | −150,000 | $0.08 | $12K | 16,682,019 |
| 2013-04-25 | NARINE JEENARINE Director | Returned to the company | −150,000 | $0.08 | $12K | 16,412,461 |
| 2013-04-25 | NIGALAYE ASHOK G Chief Scientific Officer | Returned to the company | −150,000 | $0.08 | $12K | 22,510,022 |
| 2013-04-25 | EPIC PHARMA LLC 10% owner | Returned to the company | −150,000 | $0.08 | $12K | 14,910,666 |
| 2013-04-25 | EPIC INVESTMENTS, LLC 10% owner | Returned to the company | −150,000 | $0.08 | $12K | 14,910,666 |
| 2013-03-25 | NIGALAYE ASHOK G Chief Scientific Officer | Other acquisition | +6,775,068 | $0.04 | $250K | 15,060,666 |
| 2013-03-25 | NIGALAYE ASHOK G Chief Scientific Officer | Other acquisition · Warrants | +6,666,667 | 2,436,665 | ||
| 2013-03-25 | NARINE JEENARINE Director | Other acquisition | +666,667 | $0.04 | $25K | 15,060,666 |
| 2013-03-25 | NARINE JEENARINE Director | Other acquisition · Warrants | +333,333 | 2,436,665 |
Page 16 of 18 · 356 trades